Funnelfeedr Logo

IRLAB Therapeutics AB

Sweden556931-4692Active

Developing novel CNS drugs for Parkinson's disease using proprietary technology.

Biotechnology Companyirlab.se

Overview

1–4
Employees
5–10M SEK
Revenue
2013
Founded

Key Decision Makers

Kristina Torfgård

CEO

@irlab.se+46730XXXXXX

Clas Sonesson

Chief Scientific Officer (CSO)

@irlab.se

Carola Lemne

Chair of the Board

@irlab.se

Nicholas Waters

Executive Vice President and Head of R&D

@irlab.se

+4 more contacts in Funnelfeedr

Description

IRLAB Therapeutics AB is a rapidly growing, publicly traded biotechnology company rooted in Nobel Prize-winning research. The organization specializes in discovering and developing novel treatments for Parkinson’s disease (PD) and other Central Nervous System (CNS) disorders. IRLAB utilizes its prop...

Tags

B2BHolding CompanyPharmaceuticalsProfessional ServicesPublicly ListedWhite Collar

Keywords

BiotechnologyCNS DisordersDrug DevelopmentISP PlatformParkinson's DiseaseTherapeutics

Company Information

Industry
Verksamheter som utövas av huvudkontor
Legal Form
Aktiebolag
VAT Number
SE556931469201

Decision Makers

8 contacts in Funnelfeedr

Kristina Torfgård

CEO

@irlab.se+46730XXXXXX

Clas Sonesson

Chief Scientific Officer (CSO)

@irlab.se

Carola Lemne

Chair of the Board

@irlab.se

Nicholas Waters

Executive Vice President and Head of R&D

@irlab.se

Joakim Tedroff

Chief Medical Officer (CMO)

@irlab.se

Gustaf Albèrt

Chief Financial Officer (CFO)

@irlab.se

Peder Svensson

Director of Computational Chemistry & Biology and Chief Information Officer (CIO)

@irlab.se

Susanna Holm Waters

Director of Systems Pharmacology

Similar Companies

20 similar companies in Funnelfeedr

Browse More

IRLAB Therapeutics AB Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo